Steven Cook Sells 1,884 Shares of Omada Health (NASDAQ:OMDA) Stock

Omada Health, Inc. (NASDAQ:OMDA) CFO Steven Cook sold 1,884 shares of Omada Health stock in a transaction that occurred on Friday, March 13th. The stock was sold at an average price of $13.94, for a total value of $26,262.96. Following the completion of the sale, the chief financial officer owned 200,512 shares in the company, valued at approximately $2,795,137.28. This represents a 0.93% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.

Omada Health Stock Down 3.5%

Shares of Omada Health stock opened at $14.11 on Thursday. The company has a market cap of $831.36 million and a PE ratio of -83.00. The business has a 50 day moving average of $13.81 and a 200 day moving average of $18.23. Omada Health, Inc. has a 52 week low of $10.28 and a 52 week high of $28.40.

Omada Health (NASDAQ:OMDA) last announced its quarterly earnings results on Thursday, March 5th. The company reported $0.08 EPS for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.12. The business had revenue of $75.85 million during the quarter.

Institutional Trading of Omada Health

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Cigna Investments Inc. New purchased a new position in Omada Health during the 3rd quarter valued at about $76,161,000. Perceptive Advisors LLC bought a new stake in Omada Health during the second quarter worth about $44,402,000. Millennium Management LLC grew its holdings in Omada Health by 1,195.0% in the fourth quarter. Millennium Management LLC now owns 2,272,168 shares of the company’s stock worth $35,855,000 after purchasing an additional 2,096,705 shares during the period. Divisadero Street Capital Management LP bought a new position in shares of Omada Health during the third quarter valued at approximately $30,510,000. Finally, Loomis Sayles & Co. L P bought a new position in shares of Omada Health during the second quarter valued at approximately $19,948,000.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the stock. Wall Street Zen raised shares of Omada Health from a “hold” rating to a “buy” rating in a research note on Saturday, March 14th. JPMorgan Chase & Co. decreased their price target on shares of Omada Health from $32.00 to $26.00 and set an “overweight” rating for the company in a research note on Thursday, March 12th. Morgan Stanley cut their price objective on Omada Health from $32.00 to $30.00 and set an “overweight” rating on the stock in a research report on Friday, March 6th. Weiss Ratings reiterated a “sell (d)” rating on shares of Omada Health in a report on Thursday, January 22nd. Finally, Barclays decreased their target price on Omada Health from $22.00 to $17.00 and set an “overweight” rating for the company in a research report on Tuesday, March 3rd. Eight research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $23.60.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.